The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.
Open accessAbstract
Erythropoietin regulates the proliferation and differentiation of erythroid precursor cells. Its effect is mediated by the erythropoietin receptor (EPOR), a member of a large family of cytokine receptors. The EPOR gene has recently been cloned, sequenced, and characterized. As shown experimentally, its intracellular C-terminal part contains a domain exerting negative control on erythropoiesis. Here we describe a G to A transition in nucleotide 6002 of the EPOR gene that converts a TGG codon for tryptophan into a TAG stop codon, predicting the truncation of the 70 C-terminal amino acids of the EPOR molecule. The mutation occurs in heterozygous form in the germ-line DNA of members of a large kindred in which primary erythrocytosis is segregating as a mild autosomal dominant trait. The mutation cosegregates with the disease phenotype in all 29 affected family members studied; it occurs in no unaffected family members or unrelated controls. This appears to be an example of a human condition caused by an EPOR mutation. Striking similarities exist between the human phenotype described here and phenotypes of cell lines expressing similarly truncated EPOR molecules produced experimentally. By analogy with these in vitro studies, one can hypothesize that the truncated EPOR molecules are activated by suppression of phosphorylation leading to loss of the down-modulation exerted by intact EPOR molecules. Experimental modifications of the EPOR gene may eventually have therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Strategies for multilocus linkage analysis in humans.
Lathrop, G. M., Lalouel, J. M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,559
Detection of single base substitutions in total genomic DNA
Myers, R. M., Lumelsky, N., Lerman, L. S., & Maniatis, T. (1985) · Nature · doi:10.1038/313495a0 · Cited by 374
Homodimerization and constitutive activation of the erythropoietin receptor.
Watowich, S. S., Yoshimura, A., Longmore, G. D., Hilton, D. J., Yoshimura, Y., & Lodish, H. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2140 · Cited by 319
Yoshimura, A., Longmore, G., & Lodish, H. F. (1990) · Nature · doi:10.1038/348647a0 · Cited by 308
D'Andrea, A. D., Yoshimura, A., Youssoufian, H., Zon, L. I., Koo, J. W., & Lodish, H. F. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1980 · Cited by 279
Human erythropoietin receptor: cloning, expression, and biologic characterization
Jones, S., D'Andrea, A., Haines, L., & Wong, G. (1990) · Blood · doi:10.1182/blood.v76.1.31.31 · Cited by 240
Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.
Miura, O., D'Andrea, A., Kabat, D., & Ihle, J. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4895 · Cited by 224
Longmore, G. D., & Lodish, H. F. (1991) · Cell · doi:10.1016/0092-8674(91)90286-8 · Cited by 151
A Truncated Erythropoietin Receptor That Fails to Prevent Programmed Cell Death of Erythroid Cells
Nakamura, Y., Komatsu, N., & Nakauchi, H. (1992) · Science · doi:10.1126/science.257.5073.1138 · Cited by 145
Cited by
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
Klingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90351-8 · Cited by 929
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07281.x · Cited by 753
Hershey, G. K. K., Friedrich, M. F., Esswein, L. A., Thomas, M. L., & Chatila, T. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372403 · Cited by 748
Inside the brain of an elite athlete: the neural processes that support high achievement in sports
Yarrow, K., Brown, P., & Krakauer, J. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2672 · Cited by 637
Lineage-Specific Hematopoietic Growth Factors
Kaushansky, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052706 · Cited by 509
New mutations and pathogenesis of myeloproliferative neoplasms
Vainchenker, W., Delhommeau, F., Constantinescu, S. N., & Bernard, O. A. (2011) · Blood · doi:10.1182/blood-2011-02-292102 · Cited by 395
Yi, T., Mui, A. L.-F., Krystal, G., & Ihle, J. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7577-7586.1993 · Cited by 336
The Jak-Stat pathway in normal and perturbed hematopoiesis
Ward, A. C., Touw, I., & Yoshimura, A. (2000) · Blood · doi:10.1182/blood.v95.1.19 · Cited by 313
Cytokine receptor signaling through the Jak–Stat–Socs pathway in disease
O'Sullivan, L. A., Liongue, C., Lewis, R. S., Stephenson, S. E. M., & Ward, A. C. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.025 · Cited by 308
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
Moliterno, A. R., Hankins, W. D., & Spivak, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380903 · Cited by 302
Philadelphia chromosome–like acute lymphoblastic leukemia
Tasian, S. K., Loh, M. L., & Hunger, S. P. (2017) · Blood · doi:10.1182/blood-2017-06-743252 · Cited by 296
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288
Negative regulation of the JAK/STAT pathway
Starr, R., & Hilton, D. J. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199901)21:1<47::aid-bies6>3.0.co;2-n · Cited by 287
Negative regulation of cytokine signaling
Greenhalgh, C. J., & Hilton, D. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.3.348 · Cited by 258
“carry a mutant EPO receptor that is truncated and unable to bind SHP-1 [13].”
BackgroundThe function of the protein tyrosine phosphatase SHP-1 in cancer
Wu, C. (2003) · Gene · doi:10.1016/s0378-1119(03)00400-1 · Cited by 225
The HIF pathway and erythrocytosis
Lee, F. S., & Percy, M. J. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130321 · Cited by 177
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove
Percy, M. J., Furlow, P. W., Beer, P. A., Lappin, T. R. J., McMullin, M. F., & Lee, F. S. (2007) · Blood · doi:10.1182/blood-2007-04-084434 · Cited by 155
Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain
Drachman, J. G., & Kaushansky, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2350 · Cited by 153
G protein-coupled receptor structure and function: the impact of disease-causing mutations
Shenker, A. (1995) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80519-2 · Cited by 81
Exercise genomics—a paradigm shift is needed: a commentary
Bouchard, C. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095294 · Cited by 63
A Gain-of-Function Mutation in EPO in Familial Erythrocytosis
Zmajkovic, J., Lundberg, P., Nienhold, R., Torgersen, M. L., Sundan, A., Waage, A., & Skoda, R. C. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709064 · Cited by 56
Tour de France Champions born or made: where do we take the genetics of performance?
Moran, C. N., & Pitsiladis, Y. P. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1215494 · Cited by 32
Metadata
- Authors
- de la Chapelle, A., Träskelin, A. L., & Juvonen, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-05-15
- Volume
- 90
- Issue
- 10
- Pages
- 4495-4499
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2153697948
- Cited by
- 407
- References
- 23
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.